Summary Comments on Results
Commenting on the results, President and Chief Executive Officer, Dr. Jeffrey Graves said, “During my first year at 3D Systems, we established a clear strategic purpose that is driving our work every day: To be leaders in enabling additive manufacturing solutions for applications in growing markets that demand high-reliability products. We laid out a four-stage plan to reach that goal and I am pleased that these efforts have contributed to impressive Q1 results. We delivered almost 8% year-over-year revenue growth despite divestments of non-core businesses in 2020 and 2021. When we exclude the revenue from these divested businesses, organic revenue grew nearly 17%. Our Healthcare business continues to deliver exceptional growth, posting a 39% year-over-year increase, with strength in both dental and medical applications. Industrial sales continue to stabilize as global economies gradually open up from the pandemic. We believe the exciting growth our company is now delivering is the result of two factors. One is the ongoing opportunity for additive manufacturing to enhance the design and manufacturing processes of our customers, and the second is our ability to leverage our exceptional technology portfolio, solutions strategy, and intense focus on execution.
In conjunction with our topline growth, we have also maintained a tight focus on our cost structure, generating gross margins of 44%, an almost two-point improvement year-over-year, and double-digit adjusted-EBITDA margins. This combination of strong top line growth, profitability, and cash generation distinguishes us in our industry. We attribute this performance to the breadth of our technology portfolio, which includes industrial metal and polymer systems, leading edge software solutions, and a rapidly increasing range of materials for both human and industrial application. This technology base, brought to an intense focus through high value customer applications, creates an exciting environment for sustained value creation for all our stakeholders.”
Dr. Graves continued, “With our solid progress on the initial stages of our transformation plan, we have now increased our focus on the fourth stage of our plan, which is to invest for accelerated growth and profitability in support of our long-term financial goals of sustained double-digit revenue growth, 50% gross profit margins and 20% adjusted-EBITDA margins. Our recently announced acquisitions of Allevi, a developer of bioprinting solutions, comprising bioprinters, biomaterials, and specialized laboratory software, and Additive Works, a software company focused on optimization and automation of AM print setup and workflow generation, are key steps to reaching our long term goals. In addition to these two exciting acquisitions, last week we announced an investment to expand our operations in Colorado, which will allow us to meet the increasing demand for our industry-leading Healthcare solutions that target patient-specific applications, while also expanding our industrial application development capabilities, spearheaded by our Application Innovation Group, adding expertise and technology to address new, more complex industrial applications.”
Dr. Graves summarized, “I’m very proud of our teams’ performance in the first quarter of the year and am excited about our trajectory and the long-term potential of our company. More than ever, I believe that additive manufacturing will play a key role in transforming the way components can be designed and manufactured for critical applications ranging from complex aerospace systems, to electric vehicles, to even the human body. Our strong financial performance and balance sheet, combined with industry leading technology and application expertise, will allow us to lead that transformation.”
Summary of First Quarter Results
Revenue for the first quarter of 2021 increased 7.7% compared to the same period last year, and excluding businesses divested in 2020 and 2021, increased 16.6%. The results reflect strong performance in Healthcare and a continued stabilization of Industrial as economies around the world reopen from pandemic-related shutdowns. Revenue from Healthcare increased 38.7% to $72.5 million, compared to the same period last year, driven by strong sales in both dental applications and medical applications. Industrial sales decreased 11.7% to $73.6 million, compared to the same period last year; excluding businesses divested in 2020 and 2021, Industrial sales increased 0.7%.
Gross profit margin in the first quarter of 2021 was 44.0% compared to 42.1% in the same period last year. Non-GAAP gross profit margin was 44.0% compared to 42.7% in the same period last year.
Operating expenses decreased 12.1% to $66.2 million in the first quarter of 2021, compared to the same period a year ago. On a non-GAAP basis, operating expenses were $51.2 million, an 18.7% decrease from the first quarter of the prior year. The lower non-GAAP operating expenses reflect savings achieved from cost restructuring activities.
Financial Liquidity
At March 31, 2021, the company had cash on hand of $133.0 million including restricted cash, no debt and a $100 million unused revolving credit facility with approximately $92.0 million of availability based on the terms of the agreement. Cash on hand has increased $48.2 million since December 31, 2020, driven primarily by net proceeds from divestitures of $54.7 million and cash generated from operations of $28.5 million, offset by a debt repayment of $21.4 million and other financing and investing uses of cash.
Q1 2021 Conference Call and Webcast
3D Systems expects to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 with the Securities and Exchange Commission today, May 10, 2021. The company will host a conference call and simultaneous webcast to discuss these results tomorrow morning, which may be accessed as follows:
Date: Tuesday, May 11, 2021
Time: 8:30 a.m. Eastern Time
Listen via webcast:
www.3dsystems.com/investor
Participate via telephone: 201-689-8345
A replay of the webcast will be available approximately two hours after the live presentation at www.3dsystems.com/investor.
Forward-Looking Statements
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward looking statements can be identified by terms such as “believes,” “belief,” “expects,” “may,” “will,” “estimates,” “intends,” “anticipates” or “plans” or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise.
Presentation of Information in this Press Release
3D Systems reports is financial results in accordance with GAAP. To facilitate a better understanding of the impact that strategic acquisitions, non-recurring charges and certain non-cash expenses had on its financial results, management reviews certain non-GAAP measures, including non-GAAP Operating Income, non-GAAP Net Income (Loss), non-GAAP Basic and Diluted Income (Loss) per Share, non-GAAP Gross Profit, non-GAAP Gross Profit Margin, non-GAAP SG&A Expenses and non-GAAP Operating Expenses, each of which exclude the impact of amortization of intangibles, acquisition and severance expenses, stock-based compensation expense, litigation settlements and charges related to strategic decisions and portfolio realignment, and Adjusted EBITDA, defined as non-GAAP Operating Income plus depreciation, and Adjusted EBITDA Margins to better evaluate period-over-period performance. A reconciliation of GAAP to non-GAAP results is provided in the accompanying schedule.
